Literature DB >> 15961414

Frataxin interacts functionally with mitochondrial electron transport chain proteins.

Pilar González-Cabo1, Rafael P Vázquez-Manrique, M Adelaida García-Gimeno, Pascual Sanz, Francesc Palau.   

Abstract

Frataxin deficiency is the main cause of Friedreich ataxia, an autosomal recessive neurodegenerative disorder. Frataxin function in mitochondria has not been fully explained yet. In this work, we show that Saccharomyces cerevisiae frataxin orthologue Yfh1p interacts physically with succinate dehydrogenase complex subunits Sdh1p and Sdh2p of the yeast mitochondrial electron transport chain and also with electron transfer flavoprotein complex ETFalpha and ETFbeta subunits from the electron transfer flavoprotein complex. Genetic synthetic interaction experiments confirmed a functional relationship between YFH1 and succinate dehydrogenase genes SDH1 and SDH2. We also demonstrate a physical interaction between human frataxin and human succinate dehydrogenase complex subunits, suggesting also a key role of frataxin in the mitochondrial electron transport chain in humans. Consequently, we suggest a direct participation of the respiratory chain in the pathogenesis of the Friedreich ataxia, which we propose to be considered as an OXPHOS disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961414     DOI: 10.1093/hmg/ddi214

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  49 in total

1.  HSC20 interacts with frataxin and is involved in iron-sulfur cluster biogenesis and iron homeostasis.

Authors:  Yuxi Shan; Gino Cortopassi
Journal:  Hum Mol Genet       Date:  2011-12-13       Impact factor: 6.150

2.  Reduced expression of mitochondrial frataxin in mice exacerbates diet-induced obesity.

Authors:  Doreen Pomplun; Anja Voigt; Tim J Schulz; René Thierbach; Andreas F Pfeiffer; Michael Ristow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

Review 3.  Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.

Authors:  Ngolela E Babady; Nadege Carelle; Robert D Wells; Tracey A Rouault; Michio Hirano; David R Lynch; Martin B Delatycki; Robert B Wilson; Grazia Isaya; Hélène Puccio
Journal:  Mol Genet Metab       Date:  2007-06-26       Impact factor: 4.797

4.  Deletion of the Proposed Iron Chaperones IscA/SufA Results in Accumulation of a Red Intermediate Cysteine Desulfurase IscS in Escherichia coli.

Authors:  Jing Yang; Guoqiang Tan; Ting Zhang; Robert H White; Jianxin Lu; Huangen Ding
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

5.  Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.

Authors:  Belén Mollá; Diana C Muñoz-Lasso; Pablo Calap; Angel Fernandez-Vilata; María de la Iglesia-Vaya; Federico V Pallardó; Maria Dolores Moltó; Francesc Palau; Pilar Gonzalez-Cabo
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

6.  Triple therapy with darbepoetin alfa, idebenone, and riboflavin in Friedreich's ataxia: an open-label trial.

Authors:  Javier Arpa; Irene Sanz-Gallego; Francisco J Rodríguez-de-Rivera; Francisco J Domínguez-Melcón; Daniel Prefasi; Javier Oliva-Navarro; Mar Moreno-Yangüela; Samuel I Pascual-Pascual
Journal:  Cerebellum       Date:  2013-10       Impact factor: 3.847

Review 7.  Frataxin and mitochondrial FeS cluster biogenesis.

Authors:  Timothy L Stemmler; Emmanuel Lesuisse; Debkumar Pain; Andrew Dancis
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

8.  GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.

Authors:  Sahar Al-Mahdawi; Ricardo Mouro Pinto; Dhaval Varshney; Lorraine Lawrence; Margaret B Lowrie; Sian Hughes; Zoe Webster; Julian Blake; J Mark Cooper; Rosalind King; Mark A Pook
Journal:  Genomics       Date:  2006-08-17       Impact factor: 5.736

9.  Flavin adenine dinucleotide rescues the phenotype of frataxin deficiency.

Authors:  Pilar Gonzalez-Cabo; Sheila Ros; Francesc Palau
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.